Paper22005299
Glucose and collagen regulate human platelet activity through aldose reductase induction of thromboxane.
Tang WH and 15 others. J Clin Invest, 2011. Cited by 102 papers, by iCite.
Cite this record
ConductScience Library. Glucose and collagen regulate human platelet activity through aldose reductase induction of thromboxane. Papers, record 22005299. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/22005299
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics27
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Aldehyde Reductase | Major topic |
| Blood Glucose | Major topic |
| Collagen | Major topic |
| Platelet Activation | Major topic |
| Thromboxanes | Major topic |
| Adult | |
| Aged | |
| Aged, 80 and over | |
| Aspirin | |
| Case-Control Studies | |
| Diabetes Mellitus | |
| Enzyme Inhibitors | |
| Female | |
| Humans | |
| In Vitro Techniques | |
| Male | |
| Middle Aged | |
| Mitogen-Activated Protein Kinase 14 | |
| Models, Biological | |
| Oxidative Stress | |
| Phospholipase C gamma | |
| Platelet Aggregation | |
| Platelet Aggregation Inhibitors | |
| Protein Kinase C | |
| Reactive Oxygen Species | |
| Signal Transduction | |
| Venous Thrombosis |
Source PubMed
Grants1
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| R01 HL074190 | NHLBI NIH HHS | United States | R01HL074190 | PubMed and NIH |
Source NIH RePORTER
References54
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 2841328 | Purification and characterization of membrane-bound phospholipase C specific for phosphoinositides from human platelets. | J Biol Chem | 1988 | https://conductscience.org/library/papers/2841328 | PubMed |
| 2 | 6381035 | Aspects of the pathogenesis of type 2 diabetes. | Endocr Rev | 1984 | https://conductscience.org/library/papers/6381035 | PubMed |
| 3 | 15304032 | Platelet activation in type 2 diabetes mellitus. | J Thromb Haemost | 2004 | https://conductscience.org/library/papers/15304032 | PubMed |
| 4 | 18447661 | Epalrestat: an aldose reductase inhibitor for the treatment of diabetic neuropathy. | Pharmacotherapy | 2008 | https://conductscience.org/library/papers/18447661 | PubMed |
| 5 | 1419150 | Aldose reductase: congenial and injurious profiles of an enigmatic enzyme. | Biochem Med Metab Biol | 1992 | https://conductscience.org/library/papers/1419150 | PubMed |
| 6 | 2541501 | Studies of inositol phospholipid-specific phospholipase C. | Science | 1989 | https://conductscience.org/library/papers/2541501 | PubMed |
| 7 | 7487883 | Syk interacts with tyrosine-phosphorylated proteins in human platelets activated by collagen and cross-linking of the Fc gamma-IIA receptor. | Biochem J | 1995 | https://conductscience.org/library/papers/7487883 | PubMed |
| 8 | 11742414 | Biochemistry and molecular cell biology of diabetic complications. | Nature | 2001 | https://conductscience.org/library/papers/11742414 | PubMed |
| 9 | 12570936 | Association between hyperglycemia and the no-reflow phenomenon in patients with acute myocardial infarction. | J Am Coll Cardiol | 2003 | https://conductscience.org/library/papers/12570936 | PubMed |
| 10 | 9054746 | Platelet activation by superoxide anion and hydroxyl radicals intrinsically generated by platelets that had undergone anoxia and then reoxygenated. | Circulation | 1997 | https://conductscience.org/library/papers/9054746 | PubMed |
| 11 | 9892215 | Role of oxidative stress in diabetic complications: a new perspective on an old paradigm. | Diabetes | 1999 | https://conductscience.org/library/papers/9892215 | PubMed |
| 12 | 11672473 | Increased platelet aggregation in diabetic patients with microangiopathy despite good glycemic control. | Platelets | 2001 | https://conductscience.org/library/papers/11672473 | PubMed |
| 13 | 1411571 | Intracellular signaling by hydrolysis of phospholipids and activation of protein kinase C. | Science | 1992 | https://conductscience.org/library/papers/1411571 | PubMed |
| 14 | 12446057 | Is blood glucose an independent predictor of mortality in acute myocardial infarction in the thrombolytic era? | J Am Coll Cardiol | 2002 | https://conductscience.org/library/papers/12446057 | PubMed |
| 15 | 16127462 | Human aldose reductase expression accelerates diabetic atherosclerosis in transgenic mice. | J Clin Invest | 2005 | https://conductscience.org/library/papers/16127462 | PubMed |
| 16 | 15821004 | Association between hyper- and hypoglycaemia and 2 year all-cause mortality risk in diabetic patients with acute coronary events. | Eur Heart J | 2005 | https://conductscience.org/library/papers/15821004 | PubMed |
| 17 | 16801576 | Long-term clinical effects of epalrestat, an aldose reductase inhibitor, on diabetic peripheral neuropathy: the 3-year, multicenter, comparative Aldose Reductase Inhibitor-Diabetes Complications Trial. | Diabetes Care | 2006 | https://conductscience.org/library/papers/16801576 | PubMed |
| 18 | 7245119 | Some characteristics of mouse platelet aggregation and a comparison of the activity of a range of compounds in mouse and human platelet-rich plasma in vitro. | Thromb Haemost | 1981 | https://conductscience.org/library/papers/7245119 | PubMed |
| 19 | 12324561 | COX inhibitors and thromboregulation. | N Engl J Med | 2002 | https://conductscience.org/library/papers/12324561 | PubMed |
| 20 | 20088941 | Postprandial hyperglycemia is a determinant of platelet activation in early type 2 diabetes mellitus. | J Thromb Haemost | 2010 | https://conductscience.org/library/papers/20088941 | PubMed |
Cited by63
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 102 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42107887 | Systemic metabolic dysfunction drives platelet-mediated inflammation, fibrogenesis, and hepatocarcinogenesis in metabolic dysfunction-associated steatotic liver disease. | Clin Mol Hepatol | 2026 | https://conductscience.org/library/papers/42107887 | PubMed |
| 41772330 | MicroRNAs in type 2 diabetes mellitus and its cardiovascular complications: mechanistic insights and translational potential. | Intern Emerg Med | 2026 | https://conductscience.org/library/papers/41772330 | PubMed |
| 40823012 | Sulforaphane attenuates aldose reductase-mediated platelet dysfunction in high glucose-stimulated human platelets via downregulation of the Src/ROS/p53 signaling pathway. | Front Nutr | 2025 | https://conductscience.org/library/papers/40823012 | PubMed |
| 40775339 | Acetylsalicylic acid and vorapaxar are less active, while 4-methylcatechol is more active, in type 1 diabetic patients compared to healthy controls. | Cardiovasc Diabetol | 2025 | https://conductscience.org/library/papers/40775339 | PubMed |
| 39995796 | Evaluation of Complete Blood Count Parameters in Patients With Diabetes Mellitus: A Systematic Review. | Health Sci Rep | 2025 | https://conductscience.org/library/papers/39995796 | PubMed |
| 39920555 | Hydrogen sulphide alleviates platelet dysfunction in patients with type 2 diabetes. | J Thromb Thrombolysis | 2025 | https://conductscience.org/library/papers/39920555 | PubMed |
| 38672744 | Platelet, Antiplatelet Therapy and Metabolic Dysfunction-Associated Steatotic Liver Disease: A Narrative Review. | Life (Basel) | 2024 | https://conductscience.org/library/papers/38672744 | PubMed |
| 38592258 | The Interplay between Liver Sinusoidal Endothelial Cells, Platelets, and Neutrophil Extracellular Traps in the Development and Progression of Metabolic Dysfunction-Associated Steatotic Liver Disease. | J Clin Med | 2024 | https://conductscience.org/library/papers/38592258 | PubMed |
| 38275633 | The Influence of Caramel Carbon Quantum Dots and Caramel on Platelet Aggregation, Protein Glycation and Lipid Peroxidation. | Antioxidants (Basel) | 2023 | https://conductscience.org/library/papers/38275633 | PubMed |
| 38132873 | Key Therapeutic Targets to Treat Hyperglycemia-Induced Atherosclerosis Analyzed Using a Petri Net-Based Model. | Metabolites | 2023 | https://conductscience.org/library/papers/38132873 | PubMed |
| 37502132 | A guide to molecular and functional investigations of platelets to bridge basic and clinical sciences. | Nat Cardiovasc Res | 2022 | https://conductscience.org/library/papers/37502132 | PubMed |
| 37490001 | Platelet-derived lipids promote insulin secretion of pancreatic β cells. | EMBO Mol Med | 2023 | https://conductscience.org/library/papers/37490001 | PubMed |
| 36672299 | Tumor-Educated Platelet Extracellular Vesicles: Proteomic Profiling and Crosstalk with Colorectal Cancer Cells. | Cancers (Basel) | 2023 | https://conductscience.org/library/papers/36672299 | PubMed |
| 36627944 | Type 2 Diabetes Mellitus, Platelet Activation and Alzheimer's Disease: A Possible Connection. | Clin Neuropsychiatry | 2022 | https://conductscience.org/library/papers/36627944 | PubMed |
| 36588714 | Characterization of the acetylation of cyclooxygenase-isozymes and targeted lipidomics of eicosanoids in serum and colon cancer cells by the new aspirin formulation IP1867B versus aspirin in vitro. | Front Pharmacol | 2022 | https://conductscience.org/library/papers/36588714 | PubMed |
| 35862006 | Unfolded Protein Response Differentially Modulates the Platelet Phenotype. | Circ Res | 2022 | https://conductscience.org/library/papers/35862006 | PubMed |
| 35835141 | Endothelial Dysfunction and Platelet Hyperactivation in Diabetic Complications Induced by Glycemic Variability. | Horm Metab Res | 2022 | https://conductscience.org/library/papers/35835141 | PubMed |
| 35624860 | Redox Mechanisms of Platelet Activation in Aging. | Antioxidants (Basel) | 2022 | https://conductscience.org/library/papers/35624860 | PubMed |
| 35563363 | Non-Traditional Pathways for Platelet Pathophysiology in Diabetes: Implications for Future Therapeutic Targets. | Int J Mol Sci | 2022 | https://conductscience.org/library/papers/35563363 | PubMed |
| 35280973 | COVID-19 Induced Coagulopathy (CIC): Thrombotic Manifestations of Viral Infection. | TH Open | 2022 | https://conductscience.org/library/papers/35280973 | PubMed |
Genes5
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| AKR1A1 | 10327 | PubTator's text mining | https://conductscience.org/library/genes/10327 | NCBI Gene |
| AKR1B1 | 231 | PubTator's text mining | https://conductscience.org/library/genes/231 | NCBI Gene |
| MAPK14 | 1432 | PubTator's text mining | https://conductscience.org/library/genes/1432 | NCBI Gene |
| PLCG2 | 5336 | PubTator's text mining | https://conductscience.org/library/genes/5336 | NCBI Gene |
| PRRT2 | 112476 | PubTator's text mining | https://conductscience.org/library/genes/112476 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/22005299
GET https://conductscience.org/api/papers/v1/22005299/references?page=2